Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 2—February 2019
Historical Review

Killing Clothes Lice by Holding Infested Clothes Away from Hosts for 10 Days to Control Louseborne Relapsing Fever, Bahir Dah, Ethiopia

Stephen C. BarkerComments to Author  and Dayana Barker
Author affiliations: University of Queensland, Brisbane, Queensland, Australia (S.C. Barker); University of Queensland School of Veterinary Sciences, Gatton, Queensland, Australia (D. Barker)

Main Article

Figure 3

Mortality rates for Pediculus humanus clothes lice, Ethiopia. Dark red shading indicates 100% mortality rate and light red shading <100% mortality rate for eggs. At 8°C–19°C, a total of 100% of eggs did not hatch; at 24°C, a total of 89% of eggs did not hatch (those that hatched took 14.5 days [range 13–19 days] to hatch); at 26°C, a total of 66% of eggs did not hatch; and at 29°C, a total of 12% of eggs did not hatch (88% hatched). Dotted lines denote 12% (top) and 100% (bottom) mortality ra

Figure 3. Mortality rates for the eggs of Pediculus humanus clothes lice, Ethiopia. Dark red shading indicates 100% mortality rate and light red shading <100% mortality rate for eggs. At 8°C–19°C, a total of 100% of eggs did not hatch; at 24°C, a total of 89% of eggs did not hatch (those that hatched took 14.5 days [range 13–19 days] to hatch); at 26°C, a total of 66% of eggs did not hatch; and at 29°C, a total of 12% of eggs did not hatch (88% hatched). Dotted lines denote 12% (top) and 100% (bottom) mortality rate temperatures. Data were obtained from Leeson (41).

Main Article

References
  1. Elbir  H, Raoult  D, Drancourt  M. Relapsing fever borreliae in Africa. Am J Trop Med Hyg. 2013;89:288–92. DOIPubMedGoogle Scholar
  2. Boutellis  A, Mediannikov  O, Bilcha  KD, Ali  J, Campelo  D, Barker  SC, et al. Borrelia recurrentis in head lice, Ethiopia. Emerg Infect Dis. 2013;19:796–8. DOIPubMedGoogle Scholar
  3. Antinori  S, Mediannikov  O, Corbellino  M, Grande  R, Parravicini  C, Bestetti  G, et al. Louse-borne relapsing fever (Borrelia recurrentis) in a Somali refugee arriving in Italy: a re-emerging infection in Europe? PLoS Negl Trop Dis. 2016;10:e0004522. DOIPubMedGoogle Scholar
  4. Antinori  S, Mediannikov  O, Corbellino  M, Raoult  D. Louse-borne relapsing fever among East African refugees in Europe. Travel Med Infect Dis. 2016;14:110–4. DOIPubMedGoogle Scholar
  5. Ciervo  A, Mancini  F, di Bernardo  F, Giammanco  A, Vitale  G, Dones  P, et al. Louseborne relapsing fever in young migrants, Sicily, Italy, July–September 2015. Emerg Infect Dis. 2016;22:152–3. DOIPubMedGoogle Scholar
  6. Colomba  C, Scarlata  F, Di Carlo  P, Giammanco  A, Fasciana  T, Trizzino  M, et al. Fourth case of louse-borne relapsing fever in Young Migrant, Sicily, Italy, December 2015. Mini Review Article. Public Health. 2016;139:22–6. DOIPubMedGoogle Scholar
  7. Costescu Strachinaru  DI, Cambier  J, Kandet-Yattara  H, Konopnicki  D. Relapsing fever in asylum seekers from Somalia arriving in Belgium in August 2015. Acta Clin Belg. 2016;•••:1–3.PubMedGoogle Scholar
  8. Cutler  SJ. Refugee crisis and re-emergence of forgotten infections in Europe. Clin Microbiol Infect. 2016;22:8–9. DOIPubMedGoogle Scholar
  9. Cutuli  SL, De Pascale  G, Spanu  T, Dell’Anna  AM, Bocci  MG, Pallavicini  F, et al. Lice, rodents, and many hopes: a rare disease in a young refugee. Crit Care. 2017;21:81. DOIPubMedGoogle Scholar
  10. Darcis  G, Hayette  MP, Bontems  S, Sauvage  AS, Meuris  C, Van Esbroeck  M, et al. Louse-borne relapsing fever in a refugee from Somalia arriving in Belgium. J Travel Med. 2016;23:taw009. https://doi.org/10.1093/jtm/taw009
  11. Grecchi  C, Zanotti  P, Pontarelli  A, Chiari  E, Tomasoni  LR, Gulletta  M, et al. Louse-borne relapsing fever in a refugee from Mali. Infection. 2017;45:373–6. DOIPubMedGoogle Scholar
  12. Hytönen  J, Khawaja  T, Grönroos  JO, Jalava  A, Meri  S, Oksi  J. Louse-borne relapsing fever in Finland in two asylum seekers from Somalia. APMIS. 2017;125:59–62. DOIPubMedGoogle Scholar
  13. Jochum  J, Tannich  E, Tappe  D, Schmiedel  S. [A Somali refugee with fever and abnormal blood smear] [in German]. Internist (Berl). 2017;58:287–92. DOIPubMedGoogle Scholar
  14. Keller  C, Zumblick  M, Streubel  K, Eickmann  M, Müller  D, Kerwat  M, et al. Hemorrhagic diathesis in Borrelia recurrentis infection imported to Germany. Emerg Infect Dis. 2016;22:917–9. DOIPubMedGoogle Scholar
  15. Lucchini  A, Lipani  F, Costa  C, Scarvaglieri  M, Balbiano  R, Carosella  S, et al. Louseborne relapsing fever among East African refugees, Italy, 2015. Emerg Infect Dis. 2016;22:298–301. DOIPubMedGoogle Scholar
  16. Osthoff  M, Schibli  A, Fadini  D, Lardelli  P, Goldenberger  D. Louse-borne relapsing fever - report of four cases in Switzerland, June-December 2015. BMC Infect Dis. 2016;16:210. DOIPubMedGoogle Scholar
  17. Seilmaier  M, Guggemos  W, Wieser  A, Fingerle  V, Balzer  L, Fenzl  T, et al. [Louse-borne-relapsing-fever in refugees from the Horn of Africa; a case series of 25 patients] [in German]. Dtsch Med Wochenschr. 2016;141:e133–42.PubMedGoogle Scholar
  18. Seilmaier  M, Guggemos  W, Alberer  M, Wendtner  CM, Spinner  CD. Infections among refugees [in German]. Rettungsmedizin. 2017;20:216–27. DOIGoogle Scholar
  19. Zammarchi  L, Antonelli  A, Bartolini  L, Pecile  P, Trotta  M, Rogasi  PG, et al. Louse-borne relapsing fever with meningeal involvement in an immigrant from Somalia to Italy, October 2015. Vector Borne Zoonotic Dis. 2016;16:352–5. DOIPubMedGoogle Scholar
  20. Eguale  T, Abate  G, Balcha  F. Relapsing fever in Hossana, Ethiopia: a clinical and epidemiological study. Ethiop J Health Sci. 2002;12:103–8.
  21. Sundnes  KO, Haimanot  AT. Epidemic of louse-borne relapsing fever in Ethiopia. Lancet. 1993;342:1213–5. DOIPubMedGoogle Scholar
  22. Kassa  AW, Mosie  TB. Relapsing fever outbreak investigation in Bahir-Dar, Amhara Region, Ethiopia. Science Journal of Public Health. 2014;2:284–7. DOIGoogle Scholar
  23. Yimer  M, Mulu  W, Ayalew  W, Abera  B. Louse-borne relapsing fever profile at Felegehiwot referral hospital, Bahir Dar city, Ethiopia: a retrospective study. BMC Res Notes. 2014b;7:250. DOIPubMedGoogle Scholar
  24. Yimer  M, Abera  B, Mulu  W, Bezabib  B. Knowledge, attitude and practices of high risk populations on louse- borne relapsing fever in Bahir Dar city, north-west Ethiopia. Science Journal of Public Health. 2014;2:15–22. DOIGoogle Scholar
  25. Yimer  M, Abera  B, Mulu  W, Bezabih  B, Mohammed  J. Prevalence and risk factors of louse-borne relapsing fever in high risk populations in Bahir Dar city Northwest, Ethiopia. BMC Res Notes. 2014a;7:615. DOIPubMedGoogle Scholar
  26. Lloyd  L, Byam  W. Lice and their menace to man: Edinburgh (UK): Frowde; 1919.
  27. Cutler  SJ, Abdissa  A, Trape  JF. New concepts for the old challenge of African relapsing fever borreliosis. Clin Microbiol Infect. 2009;15:400–6. DOIPubMedGoogle Scholar
  28. Cutler  SJ, Bonilla  EM, Singh  RJ. Population structure of East African relapsing fever Borrelia spp. Emerg Infect Dis. 2010;16:1076–80. DOIPubMedGoogle Scholar
  29. Gratz  NG. Epidemiology of louse infestations. New York: Marcel Dekker; 1985. p. 187–98.
  30. Busvine  JR. Bionomics of lice. Scientific publication no. 263. Washington (DC): Pan American Health Organization; 1973. p. 149–68.
  31. Barker  SC, Altman  PM. A randomised, assessor blind, parallel group comparative efficacy trial of three products for the treatment of head lice in children—melaleuca oil and lavender oil, pyrethrins and piperonyl butoxide, and a “suffocation” product. BMC Dermatol. 2010;10:6. DOIPubMedGoogle Scholar
  32. Barker  SC, Altman  PM. An ex vivo, assessor blind, randomised, parallel group, comparative efficacy trial of the ovicidal activity of three pediculicides after a single application—melaleuca oil and lavender oil, eucalyptus oil and lemon tea tree oil, and a “suffocation” pediculicide. BMC Dermatol. 2011;11:14. DOIPubMedGoogle Scholar
  33. Barker  SC, Burgess  I, Meinking  TL, Mumcuoglu  KY. International guidelines for clinical trials with pediculicides. Int J Dermatol. 2012;51:853–8. DOIPubMedGoogle Scholar
  34. Mumcuoglu  KY, Friger  M, Cohen  R. Use of temperature and water immersion to control the human body louse (Anoplura: Pediculidae). J Med Entomol. 2006;43:723–5. DOIPubMedGoogle Scholar
  35. Wheeler  CM. Control of typhus in Italy 1943–-1944 by use of DDT. Am J Public Health Nations Health. 1946;36:119–29. DOIPubMedGoogle Scholar
  36. Soper  FL, Davis  WA, Markham  F, Eiehl  LA, Buck  P. Louse powder studies in North Africa. Arch de I’Institut Pasteur d’Algerie. 1943;23:183–223.
  37. Service  AP. DDT, weapon against disease. In: Service AP, editor. War Department film bulletin. United States: Bethesda (MD): NIH US National Library of Medicine digital Collections; 1945.
  38. Ramos  JM, Malmierca  E, Reyes  F, Tesfamariam  A. Results of a 10-year survey of louse-borne relapsing fever in southern Ethiopia: a decline in endemicity. Ann Trop Med Parasitol. 2008;102:467–9. DOIPubMedGoogle Scholar
  39. Cutler  SJ. Relapsing fever borreliae: a global review. Clin Lab Med. 2015;35:847–65. DOIPubMedGoogle Scholar
  40. Xiong  H, Campelo  D, Boutellis  A, Raoult  D, Alem  M, Ali  J, et al. SNPs in entire mitochondrial genome sequences (approximately 15.4 kb) and cox1 sequences (approximately 486 bp) resolve body and head lice from doubly infected people from Ethiopia, China, Nepal, and Iran but not France. J Med Entomol. 2014a;51:1199–207. DOIPubMedGoogle Scholar
  41. Leeson  HS. The effect of temperature upon the hatching of the eggs of Pediculus humanus corporis de Geer (Anoplura). Parasitology. 1941;33:243–9. DOIGoogle Scholar
  42. Buxton  PA. The louse: an account of the lice which infest man, their medical importance and control. London: Edward Arnold; 1947.
  43. Culpepper  GH. Factors influencing the rearing and maintenance of a laboratory colony of the body louse. J Econ Entomol. 1946;39:472–4. DOIPubMedGoogle Scholar
  44. Culpepper  GH. The rearing and maintenance of a laboratory colony of the body louse. Am J Trop Med. 1944;s1–24:327–9.
  45. Hunter  W. A lecture on the prevention and arrest of lice-borne diseases by new methods of disinfection. Lancet. 1918;192:347–51. DOIGoogle Scholar
  46. Hunter  W. New methods of disinfection for the prevention and arrest of lice-borne diseases (typhus, relapsing, and trench fevers). BMJ. 1918;2:198–201.PubMedGoogle Scholar
  47. Chosidow  O, Giraudeau  B, Cottrell  J, Izri  A, Hofmann  R, Mann  SG, et al. Oral ivermectin versus malathion lotion for difficult-to-treat head lice. N Engl J Med. 2010;362:896–905. DOIPubMedGoogle Scholar
  48. Pariser  DM, Meinking  TL, Bell  M, Ryan  WG. Topical 0.5% ivermectin lotion for treatment of head lice. N Engl J Med. 2012;367:1687–93. DOIPubMedGoogle Scholar

Main Article

Page created: January 18, 2019
Page updated: January 18, 2019
Page reviewed: January 18, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external